Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Getwell Pharma India is a private Indian specialty pharmaceutical company focused on manufacturing and supplying oncology generics and sterile finished dosage formulations. The company markets itself as Getwell Oncology and operates as a GMP-certified, oncology-focused manufacturer with capabilities in liquid vials, lyophilized products, powder vials, oral solids, and drug-delivery-based formulations. Its business appears centered on commercial anti-cancer products rather than novel clinical-stage drug discovery, with R&D focused on formulation innovation such as liposomal, nanoparticle, and ready-to-use injectable products. Getwell also offers CMO and licensing-oriented services and has an international footprint spanning more than 25 countries. The business has roots dating back to 1985, while the current operating entity Getwell Pharma India Private Limited was incorporated in 2017.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Get Well Pharmaceutical.